259
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome

, , , , &
Pages 2339-2348 | Published online: 10 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Marcelo Valencia, Rafael Medina, Eduardo Calixto & Noemí Rodríguez. (2022) Cerebral, Psychosocial, Family Functioning and Disability of Persons with Schizophrenia. Neuropsychiatric Disease and Treatment 18, pages 2069-2082.
Read now
Maju Mathews, Srihari Gopal, Isaac Nuamah, Ludger Hargarter, Adam J Savitz, Edward Kim, Wilson Tan, Bernardo Soares & Christoph U Correll. (2019) Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1365-1379.
Read now
Nan Li, Yu Feng, Huafei Lu, Shang Li Cai, Jianmin Zhuo, Tianmei Si & Lili Zhang. (2018) Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics. Neuropsychiatric Disease and Treatment 14, pages 825-837.
Read now

Articles from other publishers (23)

Sascha Kwakernaak, Wiepke Cahn & Richard Janssen. (2021) Is change over time in psychotic symptoms related to social functioning?. International Journal of Social Psychiatry 68:8, pages 1571-1579.
Crossref
Katarzyna Szyszko vel Chorazy, Simone Agnes Efkemann, Udo Schneider & Georg Juckel. (2022) Multi-dimensional recording of long-term treatment of patients with schizophrenic disorders compared to patients with major depression measured with the ASSESS battery. Heliyon 8:12, pages e11924.
Crossref
Alejandra Caqueo-Urízar, Felipe Ponce-Correa & Alfonso Urzúa. (2022) Effects of Recovery Measures on Internalized Stigma in Patients Diagnosed with Schizophrenia. International Journal of Mental Health and Addiction 20:6, pages 3339-3355.
Crossref
Sofia N. Oskolkova. (2022) Schizophrenia: a Narrative Review of Etiological and Diagnostic Issues. Consortium Psychiatricum 3:3, pages 20-35.
Crossref
Gurpreet Rekhi, Mei San Ang, Yiong Huak Chan, Emilio Fernandez-Egea, Brian Kirkpatrick & Jimmy Lee. (2022) Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale. Revista de Psiquiatría y Salud Mental (English Edition) 15:1, pages 3-13.
Crossref
Gurpreet Rekhi, Mei San Ang, Yiong Huak Chan, Emilio Fernandez-Egea, Brian Kirkpatrick & Jimmy Lee. (2022) Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale. Revista de Psiquiatría y Salud Mental 15:1, pages 3-13.
Crossref
Zheng Liangrong, Zhang Guican, Zhu Qi, Yang Weirui, Zhang Yaqi, Li Tong, Liang Wenjing, Zhang Ming & Guan Nianhong. (2021) Long-Term Outcomes and Predictors of Childhood-Onset Schizophrenia: A Naturalistic Study of 6-year Follow-Up in China. Frontiers in Psychiatry 12.
Crossref
Anantree Smithnaraseth, Acharaporn Seeherunwong, Rungnapa Panitrat & Mathuros Tipayamongkholgul. (2020) Hospital and patient factors influencing the health status among patients with schizophrenia, thirty days after hospital discharge: multi-level analysis. BMC Psychiatry 20:1.
Crossref
San-Ping Wang, Jung-Der Wang, Jer-Hao Chang, Bo-Jian Wu, Tso-Jen Wang & Hsiao-Ju Sun. (2020) Symptomatic remission affects employment outcomes in schizophrenia patients. BMC Psychiatry 20:1.
Crossref
San-Ping Wang, Jung-Der Wang, Jer-Hao Chang, Bo-Jian Wu, Jen-Suh Chern & Tso-Jen Wang. (2020) Frailty affects employment outcomes in patients with schizophrenia in noncompetitive employment: A 4-year longitudinal study. Schizophrenia Research 222, pages 375-381.
Crossref
Sukran Ertekin Pinar & Selma Sabanciogullari. (2020) The relationship between functional recovery and quality of life in patients affected by schizophrenia and treated at a community mental health center in Turkey. Perspectives in Psychiatric Care 56:2, pages 448-454.
Crossref
Ji Sun Kim, Young Joon Kwon, Hwa Young Lee, Ho-Sung Lee, Sungkean Kim & Se-hoon Shim. (2020) Mismatch Negativity Indices as a Prognostic Factor for Remission in Schizophrenia. Clinical Psychopharmacology and Neuroscience 18:1, pages 127-135.
Crossref
A. Vita, A.P. Perin, M. Cavanna, F. Cobelli, J. Rosa, P. Valsecchi, M. Zanigni, G. Reggiardo & E. Sacchetti. (2020) Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders. Schizophrenia Research 216, pages 243-248.
Crossref
Philip Gorwood, Sophie Bouju, Cécile Deal, Charlotte Gary, Catherine Delva, Sylvie Lancrenon & Pierre-Michel Llorca. (2019) Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission. Psychiatry Research 281, pages 112560.
Crossref
Mei San Ang, Milawaty Nurjono & Jimmy Lee. (2019) The effects of clinical illness severity and physical activity on health-related quality of life in schizophrenia. Quality of Life Research 28:6, pages 1509-1520.
Crossref
I. El Gharbi, M. Chhoumi & A. Mechri. (2019) Rémission symptomatique et sa relation avec le fonctionnement social chez des patients tunisiens suivis pour schizophrénie. L'Encéphale 45:1, pages 15-21.
Crossref
A. N. Barkhatova. (2019) Prognostic importance of the psychopathological remission structure at the initial stage of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:3, pages 5.
Crossref
Philip Gorwood, Jasmina Mallet & Sylvie Lancrenon. (2018) Functional remission in schizophrenia: A FROGS-based definition and its convergent validity. Psychiatry Research 268, pages 94-101.
Crossref
Marco Solmi, G Giorgio Pigato, Beatrice Roiter, Argentina Guaglianone, Luca Martini, Michele Fornaro, Francesco Monaco, Andrè F Carvalho, Brendon Stubbs, Nicola Veronese & Christoph U Correll. (2018) Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis. Schizophrenia Bulletin 44:5, pages 1133-1150.
Crossref
Dieter Naber, Ross A. Baker, Anna Eramo, Carlos Forray, Karina Hansen, Christophe Sapin, Timothy Peters-Strickland, Anna-Greta Nylander, Peter Hertel, Simon Nitschky Schmidt, Jean-Yves Loze & Steven G. Potkin. (2018) Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study. Schizophrenia Research 192, pages 205-210.
Crossref
J. Mallet, S. Lancrenon, P.-M. Llorca, C. Lançon, F.-J. Baylé & P. Gorwood. (2020) Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remission. European Psychiatry 47, pages 35-41.
Crossref
Faget-Agius Catherine, Vincenti Aurélie, Guedj Eric, Michel Pierre, Richieri Raphaëlle, Alessandrini Marine, Auquier Pascal, Lançon Christophe & Boyer Laurent. (2017) Defining functioning levels in patients with schizophrenia: A combination of a novel clustering method and brain SPECT analysis. Psychiatry Research: Neuroimaging 270, pages 32-38.
Crossref
Deborah Antai-Otong. (2016) Psychosocial Recovery and Rehabilitation. Nursing Clinics of North America 51:2, pages 287-297.
Crossref